White matter microstructure and its relation to clinical features of obsessive-compulsive disorder: findings from the ENIGMA OCD Working Group.
Journal
Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664
Informations de publication
Date de publication:
17 03 2021
17 03 2021
Historique:
received:
14
02
2020
accepted:
19
10
2020
revised:
15
06
2020
entrez:
18
3
2021
pubmed:
19
3
2021
medline:
29
6
2021
Statut:
epublish
Résumé
Microstructural alterations in cortico-subcortical connections are thought to be present in obsessive-compulsive disorder (OCD). However, prior studies have yielded inconsistent findings, perhaps because small sample sizes provided insufficient power to detect subtle abnormalities. Here we investigated microstructural white matter alterations and their relation to clinical features in the largest dataset of adult and pediatric OCD to date. We analyzed diffusion tensor imaging metrics from 700 adult patients and 645 adult controls, as well as 174 pediatric patients and 144 pediatric controls across 19 sites participating in the ENIGMA OCD Working Group, in a cross-sectional case-control magnetic resonance study. We extracted measures of fractional anisotropy (FA) as main outcome, and mean diffusivity, radial diffusivity, and axial diffusivity as secondary outcomes for 25 white matter regions. We meta-analyzed patient-control group differences (Cohen's d) across sites, after adjusting for age and sex, and investigated associations with clinical characteristics. Adult OCD patients showed significant FA reduction in the sagittal stratum (d = -0.21, z = -3.21, p = 0.001) and posterior thalamic radiation (d = -0.26, z = -4.57, p < 0.0001). In the sagittal stratum, lower FA was associated with a younger age of onset (z = 2.71, p = 0.006), longer duration of illness (z = -2.086, p = 0.036), and a higher percentage of medicated patients in the cohorts studied (z = -1.98, p = 0.047). No significant association with symptom severity was found. Pediatric OCD patients did not show any detectable microstructural abnormalities compared to controls. Our findings of microstructural alterations in projection and association fibers to posterior brain regions in OCD are consistent with models emphasizing deficits in connectivity as an important feature of this disorder.
Identifiants
pubmed: 33731673
doi: 10.1038/s41398-021-01276-z
pii: 10.1038/s41398-021-01276-z
pmc: PMC7969744
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
173Subventions
Organisme : NIBIB NIH HHS
ID : P41 EB015922
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Investigateurs
Francesca Assogna
(F)
Rosa Calvo
(R)
Stella J de Wit
(SJ)
Morgan Hough
(M)
Masaru Kuno
(M)
Euripedes C Miguel
(EC)
Astrid Morer
(A)
Christopher Pittenger
(C)
Sara Poletti
(S)
Enrico Smeraldi
(E)
João R Sato
(JR)
Aki Tsuchiyagaito
(A)
Susanne Walitza
(S)
Ysbrand D van der Werf
(YD)
Daniela Vecchio
(D)
Mojtaba Zarei
(M)
Références
J Psychiatry Neurosci. 2014 Sep;39(5):304-11
pubmed: 24866415
J Magn Reson B. 1996 Jun;111(3):209-19
pubmed: 8661285
Transl Psychiatry. 2017 Aug 29;7(8):e1224
pubmed: 28850108
Mol Psychiatry. 2020 Jul;25(7):1511-1525
pubmed: 31471575
Neuroimage. 2006 Jul 15;31(4):1487-505
pubmed: 16624579
Ann Neurol. 2004 Sep;56(3):407-15
pubmed: 15349868
Schizophr Res. 2015 Mar;162(1-3):22-8
pubmed: 25660467
J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):844-52
pubmed: 9183141
Brain Behav. 2017 Jan 14;7(2):e00615
pubmed: 28239525
Neuroimage. 2017 Jan 15;145(Pt B):389-408
pubmed: 26658930
Neurosci Biobehav Rev. 2015 May;52:233-57
pubmed: 25766413
Mol Psychiatry. 2020 Nov;25(11):2818-2831
pubmed: 31358905
Brain Connect. 2011;1(6):423-46
pubmed: 22432902
Neuroimage. 2008 Apr 1;40(2):570-582
pubmed: 18255316
Arch Gen Psychiatry. 2004 Jul;61(7):720-30
pubmed: 15237084
Adolesc Psychiatry. 2005;29:55-96
pubmed: 18668184
Neuropsychopharmacology. 2014 Jun;39(7):1547-57
pubmed: 24407265
Am J Psychiatry. 2008 Oct;165(10):1308-15
pubmed: 18519525
Br J Psychiatry. 2010 Aug;197(2):128-34
pubmed: 20679265
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Neurobiol Dis. 2010 Feb;37(2):468-76
pubmed: 19913616
World Psychiatry. 2007 Oct;6(3):168-76
pubmed: 18188442
Am J Psychiatry. 2016 Sep 9;174(1):60-69
pubmed: 27609241
Dev Psychopathol. 2008 Fall;20(4):1251-83
pubmed: 18838041
JAMA Psychiatry. 2014 May;71(5):582-4
pubmed: 24671770
Trends Neurosci. 2008 Jul;31(7):361-70
pubmed: 18538868
Neuroimage. 2003 Nov;20(3):1714-22
pubmed: 14642481
Eur Neuropsychopharmacol. 2013 Jul;23(7):581-93
pubmed: 22954900
Biol Mood Anxiety Disord. 2012 Mar 08;2:6
pubmed: 22737993
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
Front Psychiatry. 2019 May 10;10:319
pubmed: 31133898
Neuroimage Clin. 2016 Sep 28;12:1022-1034
pubmed: 27995068
Nat Rev Neurosci. 2015 Dec;16(12):756-67
pubmed: 26585800
Magn Reson Imaging. 2011 Jan;29(1):111-25
pubmed: 20933352
Transl Psychiatry. 2017 Mar 14;7(3):e1062
pubmed: 28291264
Nat Neurosci. 2019 Jun;22(6):992-999
pubmed: 31086316
J Psychiatr Res. 2014 Jul;54:26-35
pubmed: 24694669
Neuroimage. 2014 Jul 1;94:65-78
pubmed: 24650605
NMR Biomed. 2015 Mar;28(3):327-37
pubmed: 25639498
Mol Psychiatry. 2018 May;23(5):1261-1269
pubmed: 29038599
Nat Rev Neurosci. 2008 Dec;9(12):947-57
pubmed: 19002191
Am J Psychiatry. 2018 May 1;175(5):453-462
pubmed: 29377733
Glia. 2014 Nov;62(11):1856-77
pubmed: 25056210
Neuroscience. 2007 Apr 14;145(4):1426-38
pubmed: 17049173
Early Hum Dev. 2006 Apr;82(4):257-66
pubmed: 16360292
J Nerv Ment Dis. 2001 Jul;189(7):471-7
pubmed: 11504325
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2856-77
pubmed: 24177038
Neuropsychopharmacology. 2012 Nov;37(12):2730-9
pubmed: 22871914
Biol Mood Anxiety Disord. 2014 Dec 18;4(1):13
pubmed: 25540681
PLoS One. 2015 Jun 03;10(6):e0127118
pubmed: 26038825
Psychiatry Clin Neurosci. 2018 Jan;72(1):13-27
pubmed: 28815874